Notably, a one-year increase in KL-6 levels was most strongly associated with worsening ILD, with a hazard ratio (HR) of 2.00 (95% confidence interval [CI]: 1.29–3.11), even after adjusting for initial biomarker concentrations [50]. Here, MUC1 is linked to interstitial lung disease.